Guggenheim Capital’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-14,020
| Closed | -$212K | – | 2031 |
|
2022
Q3 | $212K | Buy |
+14,020
| New | +$212K | ﹤0.01% | 1776 |
|
2018
Q2 | – | Sell |
-5,324
| Closed | -$289K | – | 2674 |
|
2018
Q1 | $289K | Buy |
5,324
+258
| +5% | +$14K | ﹤0.01% | 2540 |
|
2017
Q4 | $303K | Sell |
5,066
-1,606
| -24% | -$96.1K | ﹤0.01% | 2489 |
|
2017
Q3 | $324K | Buy |
+6,672
| New | +$324K | ﹤0.01% | 2523 |
|
2017
Q1 | – | Sell |
-34,135
| Closed | -$1.29M | – | 2952 |
|
2016
Q4 | $1.29M | Buy |
34,135
+1,384
| +4% | +$52.4K | ﹤0.01% | 1998 |
|
2016
Q3 | $1.24M | Buy |
+32,751
| New | +$1.24M | ﹤0.01% | 1961 |
|